Clinical Trial Update: T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE [NA]

View source ↗

Summary

A clinical trial evaluating REGKINE for T-regulatory cell kinetics in stem cell transplantation was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• REGKINE

Snippet

Sponsor: Baylor College of Medicine | Conditions: Leukemia, Cancer | NA | Status: TERMINATED | Results posted: 2014-09-08